-+ 0.00%
-+ 0.00%
-+ 0.00%

NurExone Doubles Exosome Production Using Two Parallel Bioreactors

PUBT·10/22/2026 12:29:28
Listen to the news
NurExone Doubles Exosome Production Using Two Parallel Bioreactors
  • NurExone doubled exosome production using two parallel bioreactors, maintaining the same overall production time.
  • Relative yield reached 200% of single-bioreactor output, with comparable exosome quality, consistent anti-inflammatory activity and protein impurity removal above 95%.
  • The results support a modular manufacturing strategy through U.S. subsidiary Exo-Top and manufacturing partner Made Scientific.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NurExone Biologic Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220829PRIMZONEFULLFEED9851141) on October 22, 2026, and is solely responsible for the information contained therein.